Muscarinic receptors, expressed in several primary and metastatic tumours, appear to be implicated in their growth and propagation. In this work we have demonstrated that M2 muscarinic receptors are expressed in glioblastoma human specimens and in glioblastoma cell lines. Moreover, we have characterized the effects of the M2 agonist arecaidine on cell growth and survival both in two different glioblastoma cell lines (U251MG and U87MG) and in primary cultures obtained from different human biopsies. Cell growth analysis has demonstrated that the M2 agonist arecaidine strongly decreased cell proliferation in both glioma cell lines and primary cultures. This effect was dose and time dependent. FACS analysis has confirmed cell cycle arrest at G1/S and at G2/M phase in U87 cells and U251 respectively. Cell viability analysis has also shown that arecaidine induced severe apoptosis, especially in U251 cells. Chemosensitivity assays have, moreover, shown arecaidine and temozolomide similar effects on glioma cell lines, although IC50 value for arecaidine was significantly lower than temozolomide. In conclusion, we report for the first time that M2 receptor activation has a relevant role in the inhibition of glioma cell growth and survival, suggesting that M2 may be a new interesting therapeutic target to investigate for glioblastoma therapy. © 2013.

M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells / Michela, Ferretti; Cinzia, Fabbiano; DI BARI, Maria; Claudia, Conte; Emilia, Castigli; Miriam, Sciaccaluga; Ponti, Donatella; Paola, Ruggieri; Raco, Antonino; Ruggero, Ricordy; Calogero, Antonella; Tata, Ada Maria. - In: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. - ISSN 1582-1838. - ELETTRONICO. - 17:4(2013), pp. 552-566. [10.1111/jcmm.12038]

M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells

DI BARI, MARIA;PONTI, Donatella;RACO, Antonino;CALOGERO, ANTONELLA;TATA, Ada Maria
2013

Abstract

Muscarinic receptors, expressed in several primary and metastatic tumours, appear to be implicated in their growth and propagation. In this work we have demonstrated that M2 muscarinic receptors are expressed in glioblastoma human specimens and in glioblastoma cell lines. Moreover, we have characterized the effects of the M2 agonist arecaidine on cell growth and survival both in two different glioblastoma cell lines (U251MG and U87MG) and in primary cultures obtained from different human biopsies. Cell growth analysis has demonstrated that the M2 agonist arecaidine strongly decreased cell proliferation in both glioma cell lines and primary cultures. This effect was dose and time dependent. FACS analysis has confirmed cell cycle arrest at G1/S and at G2/M phase in U87 cells and U251 respectively. Cell viability analysis has also shown that arecaidine induced severe apoptosis, especially in U251 cells. Chemosensitivity assays have, moreover, shown arecaidine and temozolomide similar effects on glioma cell lines, although IC50 value for arecaidine was significantly lower than temozolomide. In conclusion, we report for the first time that M2 receptor activation has a relevant role in the inhibition of glioma cell growth and survival, suggesting that M2 may be a new interesting therapeutic target to investigate for glioblastoma therapy. © 2013.
2013
arecaidine; proliferation; apoptosis; glioblastoma; m2 muscarinic receptors; cell cycle
01 Pubblicazione su rivista::01a Articolo in rivista
M2 receptor activation inhibits cell cycle progression and survival in human glioblastoma cells / Michela, Ferretti; Cinzia, Fabbiano; DI BARI, Maria; Claudia, Conte; Emilia, Castigli; Miriam, Sciaccaluga; Ponti, Donatella; Paola, Ruggieri; Raco, Antonino; Ruggero, Ricordy; Calogero, Antonella; Tata, Ada Maria. - In: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. - ISSN 1582-1838. - ELETTRONICO. - 17:4(2013), pp. 552-566. [10.1111/jcmm.12038]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/515336
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 38
social impact